الأعمال · 7/11/20171 دقائق للقراءة
Medical Devices; Immunology and Microbiology Devices; Classification of the Genetic Health Risk Assessment System
ترجمة آلية محلية · اللغة الأصلية للمصدر
الملخص
The Food and Drug Administration (FDA, the Agency, or we) is classifying the genetic health risk assessment system into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for the genetic health risk assessment system's classification. We are taking this action because we have determined that classifying the device into class II (special controls) will provide a reasonable assurance of safety and effectiveness of the device. We believe this action will also enhance patients' access to beneficial innovative devices, in part by reducing regulatory burdens.